GOLDMAN SACHS: Buy these 13 stocks for their explosive sales growth as market-wide profits dry up

Advertisement
GOLDMAN SACHS: Buy these 13 stocks for their explosive sales growth as market-wide profits dry up

rocket takeoff

Reuters / Steve Nesius

Advertisement
  • Investors had a surprisingly sour reaction to first-quarter earnings results, even though the majority exceeded analyst forecasts.
  • That doesn't bode well for the future of equities as traders begin to prepare for a market-wide earnings growth slowdown.
  • Goldman Sachs says investors should instead focus on companies set to see strong revenue growth through the end of 2019, and singles out 13 stocks that fit the bill.

Heading into this past earnings season, analyst expectations were extremely lofty. And then something surprising happened: companies beat them anyway.

But the surprises didn't end there. Even as corporations handily exceeded forecasts, investors failed to reward them with stock gains commensurate to their outperformance, according to Goldman Sachs. To make matters even dicier, firms that missed earnings were punished to a greater extent than usual.

To say these were tough conditions is an understatement, especially considering S&P 500 earnings-per-share grew by 23% during the quarter, the most since 2011.

So what gives? Is the traditional way for traders to play earnings season outdated? Goldman has some ideas.

Advertisement

The firm argues the lack of share price follow-through stems from investors thinking - perhaps correctly - that profit growth has peaked for the cycle, leaving nowhere to go but down. It's a view that's shared across Wall Street, with firms like Morgan Stanley and BlackRock already voicing similar concerns.

Goldman has a solution for picking stocks going forward: Go further up the income statement and assess companies based on top-line revenue. The firm says that in an environment of slowing economic growth - like the one currently facing investors - it's the companies capable of growing sales that stand apart.

The chart below shows this dynamic in play. Over the past year, a Goldman-curated basket of high-revenue-growth stocks has beaten the S&P 500 by 8 percentage points, outperformance the firm expects to continue.

Screen Shot 2018 05 15 at 1.59.08 PM

Goldman Sachs

"Analysts do not expect the conditions that led to upside in 1Q EPS to persist for the remainder of this year," David Kostin, Goldman's head of US equity strategy, wrote in a client note. "In a decelerating GDP growth environment with a narrow dispersion of valuation multiples, we continue to recommend investors own stocks with the highest forecast sales growth."

Advertisement

With that in mind, all you need to do is identify the companies that fit the bill. And lucky for you, Goldman has already done the dirty work.

As mentioned above, the firm maintains a basket of companies predicted to see the biggest revenue growth. It recently went the extra step and rebalanced the index based on full-year 2019 forecasts, which informs the list below.

Without further ado, here are the 13 stocks that best fit the bill, arranged in increasing order of 2019 estimated revenue growth.

Get the latest Goldman Sachs stock price here.

{{}}

13. Adobe Systems

13. Adobe Systems

Ticker: ADBE

Industry: Information technology

Market cap: $112 billion

Year-to-date return: 38%

2019 expected sales growth: 18%

Source: Goldman Sachs

12. Alphabet

12. Alphabet

Ticker: GOOGL

Industry: Information technology

Market cap: $674 billion

Year-to-date return: 5%

2019 expected sales growth: 18%

Source: Goldman Sachs

Advertisement

11. Salesforce.com

11. Salesforce.com

Ticker: CRM

Industry: Information technology

Market cap: $92 billion

Year-to-date return: 28%

2019 expected sales growth: 19%

Source: Goldman Sachs

10. Cimarex Energy

10. Cimarex Energy

Ticker: XEC

Industry: Energy

Market cap: $9 billion

Year-to-date return: -20%

2019 expected sales growth: 20%

Source: Goldman Sachs

Advertisement

9. Vertex Pharmaceuticals

9. Vertex Pharmaceuticals

Ticker: VRTX

Industry: Healthcare

Market cap: $38 billion

Year-to-date return: 1%

2019 expected sales growth: 22%

Source: Goldman Sachs

8. Pentair

8. Pentair

Ticker: VRTX

Industry: Healthcare

Market cap: $38 billion

Year-to-date return: 1%

2019 expected sales growth: 22%

Source: Goldman Sachs

Advertisement

7. Align Technology

7. Align Technology

Ticker: ALGN

Industry: Healthcare

Market cap: $21 billion

Year-to-date return: 25%

2019 expected sales growth: 22%

Source: Goldman Sachs

6. Amazon

6. Amazon

Ticker: AMZN

Industry: Consumer discretionary

Market cap: $764 billion

Year-to-date return: 38%

2019 expected sales growth: 22%

Source: Goldman Sachs

Advertisement

5. Netflix

5. Netflix

Ticker: NFLX

Industry: Consumer discretionary

Market cap: $138 billion

Year-to-date return: 72%

2019 expected sales growth: 25%

Source: Goldman Sachs

4. Autodesk

4. Autodesk

Ticker: ADSK

Industry: Information technology

Market cap: $28 billion

Year-to-date return: 30%

2019 expected sales growth: 27%

Source: Goldman Sachs

Advertisement

3. Facebook

3. Facebook

Ticker: FB

Industry: Information technology

Market cap: $505 billion

Year-to-date return: 5%

2019 expected sales growth: 27%

Source: Goldman Sachs

2. Concho Resources

2. Concho Resources

Ticker: CXO

Industry: Energy

Market cap: $23 billion

Year-to-date return: 4%

2019 expected sales growth: 30%

Source: Goldman Sachs

Advertisement

1. Cabot Oil & Gas

1. Cabot Oil & Gas

Ticker: COG

Industry: Energy

Market cap: $10 billion

Year-to-date return: -20%

2019 expected sales growth: 34%

Source: Goldman Sachs